Brief: Impel Neuropharma Announces Q2 Non-GAAP Loss Per Share Of $0.79
16/08/2021 13:09
Aug 16 (Reuters) - Impel Neuropharma Inc IMPL.O :
* IMPEL NEUROPHARMA ANNOUNCES SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 NON-GAAP LOSS PER SHARE $0.79
* Q2 GAAP LOSS PER SHARE $1.10
Source text for Eikon: ID:nGNX6Sq64g
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq